About Single-stranded DNA-binding protein 3
Single-stranded DNA-binding protein 3 (SSBP3) is a protein
from Homo sapiens identified by UniProt accession
Q9BWW4, 388 residues long.
MolForge cross-references it against 0 known binders and
82 disease associations.
Target properties
| Protein name | Single-stranded DNA-binding protein 3 |
| UniProt accession | Q9BWW4 |
| Gene | SSBP3 |
| Organism | Homo sapiens |
| Length | 388 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (82)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.49
- neuroimaging measurement · score 0.30
- triglyceride measurement · score 0.30
- blood urea nitrogen measurement · score 0.29
- brain volume measurement · score 0.28
- cortical surface area measurement · score 0.28
- platelet count · score 0.27
- electrocardiography · score 0.27
- platelet component distribution width · score 0.27
- body weight · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BWW4-F1 | alphafold | PREDICTED | 54.36 | — |
Amino-acid sequence (388 residues)
MFAKGKGSAV PSDGQAREKL ALYVYEYLLH VGAQKSAQTF LSEIRWEKNI TLGEPPGFLH SWWCVFWDLY CAAPERRDTC EHSSEAKAFH DYSAAAAPSP VLGNIPPNDG MPGGPIPPGF FQGPPGSQPS PHAQPPPHNP SSMMGPHSQP FMSPRYAGGP RPPIRMGNQP PGGVPGTQPL LPNSMDPTRQ QGHPNMGGSM QRMNPPRGMG PMGPGPQNYG SGMRPPPNSL GPAMPGINMG PGAGRPWPNP NSANSIPYSS SSPGTYVGPP GGGGPPGTPI MPSPADSTNS SDNIYTMINP VPPGGSRSNF PMGPGSDGPM GGMGGMEPHH MNGSLGSGDI DGLPKNSPNN ISGISNPPGT PRDDGELGGN FLHSFQNDNY SPSMTMSV
Explore Single-stranded DNA-binding protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets